return to news
  1. Sudeep Pharma IPO Listing Date: What retail investors should know before NSE, BSE debut

Market News

Sudeep Pharma IPO Listing Date: What retail investors should know before NSE, BSE debut

Kamal Joshi

3 min read | Updated on November 27, 2025, 14:10 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Sudeep Pharma IPO Listing Date: The company sought to raise ₹895 crore by offering new equity shares valued at ₹95 crore and an offer for sale (OFS) conponent worth ₹800 crore.

Sudeep Pharma IPO Listing Date time share price gmp 2025 latest review allotment

A lot of Sudeep Pharma IPO consisted of 25 shares, with a price band of ₹563 to ₹593 per equity share. | Image: Sudeeppharma.com

Sudeep Pharma IPO Listing Date: Shares of Sudeep Pharma will make their stock market debut on Friday, November 28. Sudeep Pharma IPO allotment status was finalised on Wednesday, November 26.
Open FREE Demat Account within minutes!
Join now

With the listing just around the corner, here are the key details retail investors should be aware of.

Sudeep Pharma IPO: Subscription details

The initial public offering secured a robust response from all investor categories, with the issue being subscribed a total of 93.72 times. It attracted bids for 99,01,00,150 equity shares against 1,05,64,926 shares on offer, as per the National Stock Exchange (NSE) data.

CategoryReservedNo of Shares Bid ForNo of Times
Qualified Institutional Buyers (QIBs)30,18,55064,31,88,450213.08
Non-Institutional Investors (NIIs)22,63,91326,42,40,450116.72
Retail Individual Investors (RIIs)52,82,4638,26,71,25015.65
Total1,05,64,92699,01,00,15093.72

Sudeep Pharma IPO GMP

According to media reports and investorgain.com, unlisted shares of Sudeep Pharma are trading at ₹683, reflecting a grey market premium of 15.18% over the upper price band of ₹593.
Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.

Sudeep Pharma IPO objectives

Sudeep Pharma sought to raise ₹895 crore by offering new equity shares valued at ₹95 crore and an offer for sale (OFS) worth ₹800 crore.

Under the OFS, promoters Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani and Sujeet Jaysukh Bhayani HUF are offloading their stake.

The fresh issue proceeds will be used for procurement of machinery and general corporate purposes.

"In addition to the aforementioned objects, we expect to achieve the benefits of listing of the Equity Shares on the Stock Exchanges, enhancement of our company’s visibility and brand name amongst our existing and potential customers and creation of a public market for our Equity Shares in India," the company said in its red herring prospectus.

Sudeep Pharma IPO: Share credit, refund and listing date

Sudeep Pharma IPO allotment was finalised on Wednesday. Shares will be credited to the Demat account of allottees on Thursday, November 27. Refunds for non-allottees will also be processed on the same day.

The company's shares will hit the stock exchanges – the NSE and the BSE – on Friday, November 28, at 10 am.

Sudeep Pharma IPO: Financials

(₹ Crores)FY25FY24FY23
Revenue501.99459.28428.73
Total Assets717.17513.86420.11
Net Profit/(Loss)138.69133.1862.32
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story